Dexlofexidine

This classification denotes an alpha-adrenergic agonist with the molecular formula C11H12Cl2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VXJ7Z24RN1, chemically known as ( )-(s)-2-(1-(2,6-dichlorophenoxy)ethyl)-2-imidazoline but generally known as dexlofexidine, which bears US NIH Compound Identifier 208822. European Medicines Agency schedules Dexlofexidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07035MIG. The term DEXLOFEXIDINE is an International Non-Proprietary Name. DEXLOFEXIDINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dexlofexidine under HS 29332990 and SITC 51573. As of Q4 2014, DEXLOFEXIDINE remains the US FDA Preferred Term for this commodity. Dexlofexidine bears US NLM identifiers UMLS ID C2699612 and NCI Concept Code C77296. SMILES: CC(C1=NCCN1)OC2=C(C=CC=C2CL)CL.